Purpose: Central sensitization (CS) has been increasingly recognized as a key factor influencing pain perception and recovery in degenerative spinal disorders. This study aimed to investigate whether preoperative CS predicts postoperative outcomes in patients undergoing decompression surgery for lumbar spinal stenosis (LSS). Methods: Eighty-six patients with LSS who underwent decompression surgery were prospectively evaluated. CS was assessed using the Central Sensitization Inventory (CSI), with a cutoff score of ≥ 40 defining CS. Visual analogue scale (VAS) pain, Oswestry Disability Index (ODI), Hospital Anxiety and Depression Scale (HADS), and the 12-Item Short Form Health Survey (SF-12) were recorded preoperatively and at three months. Between-group comparisons and multivariate regression analyses were performed to determine the independent effect of CS on postoperative improvement. Results: Patients with CS (54.7%) reported significantly greater baseline pain, disability, and anxiety (all p <0.05). Although both groups improved postoperatively, the magnitude of improvement was smaller in CS+ patients. Between-group differences were significant for reductions in low back pain ( p =0.038), leg pain ( p =0.003), numbness ( p =0.001), disability ( p <0.001), and physical quality of life ( p <0.001). Regression analyses found that CS independently predicted poorer improvement in disability (β = +22.7, p <0.001), pain (β = +2.3, p <0.001), and physical function (β = −12.4, p <0.001), explaining up to 42% of the variance in postoperative outcomes. Conclusion: Preoperative CS is independently associated with less favorable short-term postoperative recovery following lumbar decompression for LSS. Routine assessment of CS may help identify patients at risk for suboptimal outcomes and guide individualized perioperative management.
Objective: Acute ischemic stroke is caused by a reduction in cerebral blood flow, leading to brain ischemic and subsequent cell death. The therapeutic options available for this condition are limited. The inflammatory response associated with the ischemic injury may influence the outcomes of ischemic stroke. Clarithromycin is a widely used antibiotic in medical practice. This study aimed to investigate the effect of clarithromycin on brain ischemic injury. Methods: In this study, 38 Sprague Dawley female rats were used and divided into four main groups: the pure control group, the ischemia group, the sham/control group, and the ischemic+claritromycin group. A temporary clip was placed in the bilateral carotid arteries of rats for 45 minutes. One group administered a dose of clarithromycin, and the tissue and blood samples of all four groups underwent biochemical evaluation. The results were subjected to statistical analysis. Results: The administration of clarithromycin to animals resulted in a reduction in malondialdehyde levels in brain tissues within the study group. Furthermore, Bederson's motor scores were observed to be higher in the clarithromycin-treated group in comparison to the ischemia group (p=0.092). Conclusion: A potential correlation exists between post-stroke infections and prognosis, suggesting that prophylactic antibiotic treatment may be beneficial. This study indicates that clarithromycin exerts a neuroprotective effect on cerebral ischemic injury following a stroke.
1 January 2026 in Journal of Clinical and Analytical Medicine